Authors
Calvin C Perdigao, Luqman O Ajisafe, Anju T Sunny, Si Wu, Terje Dokland, Jack A Dunkle
Published in
The Journal of biological chemistry. Pages 113595. Sep 22, 2026. Epub Sep 22, 2026.
Abstract
Type III CRISPR systems utilize a complex containing Cas10, additional Cas proteins and a crRNA to detect foreign transcripts. Upon detection, Cas10 synthesizes cyclic oligoadenylates (cOA), signaling molecules that coordinate interference by stimulating downstream enzymes with DNase, RNase, protease or other activities. Type III systems possess properties well-suited to their deployment as molecular diagnostics: specific detection and activation of a cascade of multi-turnover enzymatic reactions that can be harnessed for signal generation. We answered key questions concerning the structure and function of Serratia Cas10-Csm to facilitate its use in molecular diagnostics. We determined that Serratia Cas10-Csm (SerrCas10-Csm) synthesizes predominantly cA3 molecules and this synthesis is sensitive to mismatches in the crRNA-target RNA duplex adjacent to Cas10. To understand how Cas10 senses the presence of a bound target RNA, we determined the structure of SerrCas10-Csm unbound and bound to target RNA identifying conformational changes associated with target binding. We programmed SerrCas10-Csm with a crRNA recognizing a single nucleotide polymorphism that occurs in the human HBB transcript and is associated with sickle cell disease. We demonstrate that when the polymorphism occurs in the +1 position of the crRNA-target duplex, SerrCas10-Csm can distinguish it indicating an additional role for type III CRISPR systems in point-of-care diagnostics in low-resource settings.
PMID:
42772556
Bibliographic data and abstract were imported from PubMed on 23 Sep 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 13
- Comments 0